5348 Single-Chamber External Pulse Generator 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Medtronic Inc. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2014-05-05
  • 사례 출판 날짜
    2014-05-05
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: medtronic model 5348 single-chamber external pulse generator medical device manufacturer, medtronic inc., has issued a field safety notice concerning single-chamber external pulse generators (epgs). the affected model is 5348 and the affected serial numbers are within ranges of pep001001p to pep050019p and pep001001k to pep001714k. the manufacturer has identified a performance issue potentially affecting older model 5348 epgs manufactured between july 1995 and december 2007. this issue does not affect any other epg models or any medtronic implantable devices. through 16 april 2014, the manufacturer has determined 49 events (out of approximately 30,000 potentially affected 5348 epgs, or 0.16 percent), were related to a pacing rate outside of the intended setting, including events of sudden increased pacing rate up to the maximum setting of 180 pulses per minute (ppm). the root cause of this issue is the development of high resistance on internal electrical connector contacts due to oxidation over time. due to the unpredictable nature of the oxidation process on multiple electrical contacts, this issue may result in one or more of the following observations: pacing rate outside of the intended setting, potentially including a sudden increase in pacing rate up to the maximum setting of 180 ppm. output amplitude or sensitivity outside of intended setting. pace, sense, or low battery led indicators not lighting during power on or reset functions. rapid atrial pacing (rap) display with intermittent functionality. intermittent functionality of the on/off and rap control button. the manufacturer recommends the following actions be taken when using a potentially affected model 5348 epg: monitor the epg function and patient’s heart rhythm continuously while the epg is in use to ensure it is operating properly and delivering appropriate therapy to the patient. if any malfunction is observed with a 5348 epg, ensure the patient’s condition is stabilized, discontinue use of the model 5348 device and contact the manufacturer. according to the manufacturer, they will no longer service or repair epgs that are more than five years old, including these potentially affected 5348 epgs; which is consistent with the five-year service life of the new model 5392 epg. the manufacturer will separately communicate additional details about this new epg service policy. the manufacturer advises customers to contact them for assistance with purchasing a replacement device if customers choose to replace their potentially affected 5348 epg. according to the local supplier, the affected products were distributed in hong kong. if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 5 may 2014.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Medtronic Model 5348 Single-Chamber External Pulse Generator
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • 제조사 의견
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    DH